Gary M. Winer


As a consultant at DRC Health Care Advisors since 2015, Gary M. Winer has advised biopharmaceutical, medical device, and diagnostic companies on business strategy, product and portfolio planning and commercialization in international markets.

Previously, he served as President and Chief Executive Officer of ORGENTEC Diagnostika GmbH, a private equity-owned specialty manufacturer of autoimmune and infectious disease diagnostic tests, from April 2019 until the sale of the company in September 2021 to Sebia.

Mr. Winer held a number of senior leadership positions at Abbott and the company’s biotechnology spinoff, AbbVie, from 2003 to 2014. Most recently, he served as Vice President of Global Commercial Strategies at AbbVie (April 2014 to January 2015) and President and Chief Executive Officer of AbbVie Japan (January 2013 to April 2014). Before AbbVie’s separation from Abbott, Mr. Winer served as Divisional Vice President for the company’s Latin America and Canadian diagnostic business unit, Divisional Vice President for U.S. Commercial Operations, and Corporate Vice President and President at Abbott Japan.

Mr. Winer currently serves on the Boards of Directors of Lensar, Inc. and other private healthcare companies. Mr. Winer received a B.S. in Finance from California State University and earned an M.B.A. from Kellogg Graduate School of Management at Northwestern University.